BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1802 related articles for article (PubMed ID: 22265587)

  • 1. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Hyman BT; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Carrillo MC; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Thies B; Trojanowski JQ; Vinters HV; Montine TJ
    Alzheimers Dement; 2012 Jan; 8(1):1-13. PubMed ID: 22265587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease.
    Khachaturian ZS
    Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Jack CR; Albert MS; Knopman DS; McKhann GM; Sperling RA; Carrillo MC; Thies B; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):257-62. PubMed ID: 21514247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
    Montine TJ; Phelps CH; Beach TG; Bigio EH; Cairns NJ; Dickson DW; Duyckaerts C; Frosch MP; Masliah E; Mirra SS; Nelson PT; Schneider JA; Thal DR; Trojanowski JQ; Vinters HV; Hyman BT; ;
    Acta Neuropathol; 2012 Jan; 123(1):1-11. PubMed ID: 22101365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.
    Herrup K
    Alzheimers Dement; 2011 May; 7(3):335-7. PubMed ID: 21575876
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.
    Beach TG; Monsell SE; Phillips LE; Kukull W
    J Neuropathol Exp Neurol; 2012 Apr; 71(4):266-73. PubMed ID: 22437338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease".
    Korczyn AD
    Alzheimers Dement; 2011 May; 7(3):333-4. PubMed ID: 21575875
    [No Abstract]   [Full Text] [Related]  

  • 8. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Albert MS; DeKosky ST; Dickson D; Dubois B; Feldman HH; Fox NC; Gamst A; Holtzman DM; Jagust WJ; Petersen RC; Snyder PJ; Carrillo MC; Thies B; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):270-9. PubMed ID: 21514249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a Condensed Protocol That Reduces Effort and Cost of NIA-AA Guidelines for Neuropathologic Assessment of Alzheimer Disease.
    Flanagan ME; Marshall DA; Shofer JB; Montine KS; Nelson PT; Montine TJ; Keene CD
    J Neuropathol Exp Neurol; 2017 Jan; 76(1):39-43. PubMed ID: 28062571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Montine TJ; Monsell SE; Beach TG; Bigio EH; Bu Y; Cairns NJ; Frosch M; Henriksen J; Kofler J; Kukull WA; Lee EB; Nelson PT; Schantz AM; Schneider JA; Sonnen JA; Trojanowski JQ; Vinters HV; Zhou XH; Hyman BT
    Alzheimers Dement; 2016 Feb; 12(2):164-169. PubMed ID: 26327235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical neuropathology practice news 3-2012: the "ABC" in AD-revised and updated guideline for the neuropathologic assessment of Alzheimer's disease.
    Kovacs GG; Gelpi E
    Clin Neuropathol; 2012; 31(3):116-8. PubMed ID: 22551914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Sperling RA; Aisen PS; Beckett LA; Bennett DA; Craft S; Fagan AM; Iwatsubo T; Jack CR; Kaye J; Montine TJ; Park DC; Reiman EM; Rowe CC; Siemers E; Stern Y; Yaffe K; Carrillo MC; Thies B; Morrison-Bogorad M; Wagster MV; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):280-92. PubMed ID: 21514248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." New criteria for a new era.
    Lyketsos CG
    Alzheimers Dement; 2011 May; 7(3):328-9. PubMed ID: 21575873
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic criteria for the neuropathologic assessment of Alzheimer's disease.
    Powers JM
    Neurobiol Aging; 1997; 18(4 Suppl):S53-4. PubMed ID: 9330986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.
    Beecham GW; Hamilton K; Naj AC; Martin ER; Huentelman M; Myers AJ; Corneveaux JJ; Hardy J; Vonsattel JP; Younkin SG; Bennett DA; De Jager PL; Larson EB; Crane PK; Kamboh MI; Kofler JK; Mash DC; Duque L; Gilbert JR; Gwirtsman H; Buxbaum JD; Kramer P; Dickson DW; Farrer LA; Frosch MP; Ghetti B; Haines JL; Hyman BT; Kukull WA; Mayeux RP; Pericak-Vance MA; Schneider JA; Trojanowski JQ; Reiman EM; ; Schellenberg GD; Montine TJ
    PLoS Genet; 2014 Sep; 10(9):e1004606. PubMed ID: 25188341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 91.